Company registration number 09871865 (England and Wales)
ASK MEDICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 NOVEMBER 2025
30 November 2025
PAGES FOR FILING WITH REGISTRAR
ASK MEDICS LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 3
ASK MEDICS LIMITED
STATEMENT OF FINANCIAL POSITION
As At 30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
1,212
627
Current assets
Cash at bank and in hand
2,420
3,778
Creditors: amounts falling due within one year
Taxation and social security
114
-
0
Other creditors
33,377
27,564
33,491
27,564
Net current liabilities
(31,071)
(23,786)
Net liabilities
(29,859)
(23,159)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(29,959)
(23,259)
Total equity
(29,859)
(23,159)

The notes on pages 2 to 3 form part of these financial statements.

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 20 August 2026 and are signed on its behalf by:
Dr R Krishnaswamy
Director
Company registration number 09871865 (England and Wales)
ASK MEDICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 30 November 2025
- 2 -
1
Accounting policies
Company information

Ask Medics Limited is a private company limited by shares incorporated in England and Wales. The registered office is 8 Delfhaven Court, Standish, Wigan, Lancashire, ENGLAND, WN6 0EZ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The

Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section

1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the

historical cost convention.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

1.3
Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value

of each asset over its estimated useful life.

Plant and machinery
25% reducing balance
Computer equipment
33% straight line
1.4
Financial instruments

The following assets and liabilities are classified as financial instruments; trade debtors, Directors' loan accounts, trade creditors and accruals.

 

Financial instruments that are payable or receivable within one year, typically trade debtors, Directors' loan accounts, trade creditors and accruals and are measured initially and subsequently at the undiscounted amount of the cash or other consideration that is expected to be paid or received.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

 

Current or deferred taxation assets and liabilities are not discounted.

 

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the

statement of financial position date.

 

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

 

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits

1.6
Leases
As lessee
ASK MEDICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
For The Year Ended 30 November 2025
1
Accounting policies
(Continued)
- 3 -

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the

lease.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was.

2025
2024
Number
Number
Total
3
3
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 December 2024
5,575
Additions
1,113
At 30 November 2025
6,688
Depreciation and impairment
At 1 December 2024
4,948
Depreciation charged in the year
528
At 30 November 2025
5,476
Carrying amount
At 30 November 2025
1,212
At 30 November 2024
627
4
Related party

Included in other creditors is £31,554 (2024: £25,305) due to the Directors.

2025-11-302024-12-01falsefalsefalse20 August 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityDr R KrishnaswamyMrs S Krishnaswamy2026-08-20098718652024-12-012025-11-30098718652025-11-30098718652024-11-3009871865core:OtherPropertyPlantEquipment2025-11-3009871865core:OtherPropertyPlantEquipment2024-11-3009871865core:CurrentFinancialInstrumentscore:WithinOneYear2025-11-3009871865core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-3009871865core:WithinOneYear2025-11-3009871865core:WithinOneYear2024-11-3009871865core:CurrentFinancialInstruments2025-11-3009871865core:CurrentFinancialInstruments2024-11-3009871865core:ShareCapital2025-11-3009871865core:ShareCapital2024-11-3009871865core:RetainedEarningsAccumulatedLosses2025-11-3009871865core:RetainedEarningsAccumulatedLosses2024-11-3009871865bus:Director12024-12-012025-11-3009871865core:PlantMachinery2024-12-012025-11-3009871865core:ComputerEquipment2024-12-012025-11-30098718652023-12-012024-11-3009871865core:OtherPropertyPlantEquipment2024-11-3009871865core:OtherPropertyPlantEquipment2024-12-012025-11-3009871865bus:PrivateLimitedCompanyLtd2024-12-012025-11-3009871865bus:SmallCompaniesRegimeForAccounts2024-12-012025-11-3009871865bus:FRS1022024-12-012025-11-3009871865bus:AuditExemptWithAccountantsReport2024-12-012025-11-3009871865bus:Director22024-12-012025-11-3009871865bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP